ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Compass Therapeutics Inc

Compass Therapeutics Inc (CMPX)

2.65
-0.45
(-14.52%)
마감 26 1월 6:00AM
2.65
0.00
(0.00%)
시간외 거래: 9:55AM

실시간 토론 및 거래 아이디어: 강력한 플랫폼으로 자신있게 거래하세요.

주요 통계 및 세부정보

가격
2.65
매수가
2.62
매도가
3.20
거래량
1,788,257
2.525 일간 변동폭 3.12
0.765 52주 범위 2.73
market_cap
전일 종가
3.10
개장가
3.08
최근 거래 시간
2000
@
2.65
(formt)
마지막 거래 시간
재정 규모
US$ 4,939,282
VWAP
2.7621
평균 볼륨(3m)
1,119,396
발행 주식
137,589,171
배당수익률
-
주가수익률
-8.55
주당순이익(EPS)
-0.31
매출
-
순이익
-42.49M

Compass Therapeutics Inc 정보

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engi... Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. The company has drugged over 40 immune targets and generated a diverse pipeline of monoclonal and multispecific therapeutic candidates with potential to transform care for patients with cancer or autoimmune diseases. 더 보기

섹터
Biological Pds,ex Diagnstics
산업
Biological Pds,ex Diagnstics
본부
Wilmington, Delaware, USA
설립됨
-
Compass Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker CMPX. The last closing price for Compass Therapeutics was US$3.10. Over the last year, Compass Therapeutics shares have traded in a share price range of US$ 0.765 to US$ 2.73.

Compass Therapeutics currently has 137,589,171 shares in issue. The market capitalisation of Compass Therapeutics is US$426.53 million. Compass Therapeutics has a price to earnings ratio (PE ratio) of -8.55.

CMPX 최신 뉴스

Compass Therapeutics Provides Corporate Update and Announces Advancement of a New Drug Candidate

Top-line Phase 2/3 data readout for CTX-009, now named tovecimig (a DLL4 x VEGF-A bispecific), in patients with biliary tract cancer (BTC) is on track for end of Q1 2025.CTX-10726 (a novel PD-1 x...

Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer

BOSTON, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...

Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference

BOSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...

Compass Therapeutics to Participate in Upcoming Investor Events

BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...

Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update

Fully enrolled the Phase 2/3 trial of lead asset CTX-009 (DLL4 and VEGF-A bispecific antibody) in patients with biliary tract cancers (BTC); top-line data readout is on track for the end of the...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10.166.425702811242.492.732.349983612.5974537CS
41.08569.32907348241.5652.731.426615471.96931398CS
120.95556.34218289091.6952.731.2711193961.85362565CS
261.64162.3762376241.012.730.88017401221.73800969CS
521.2184.02777777781.442.730.7655447091.66275686CS
1560.239.50413223142.425.650.7653915642.24557131CS
260-1.45-35.36585365854.15.650.7653569042.29497973CS

CMPX - Frequently Asked Questions (FAQ)

What is the current Compass Therapeutics share price?
The current share price of Compass Therapeutics is US$ 2.65
How many Compass Therapeutics shares are in issue?
Compass Therapeutics has 137,589,171 shares in issue
What is the market cap of Compass Therapeutics?
The market capitalisation of Compass Therapeutics is USD 426.53M
What is the 1 year trading range for Compass Therapeutics share price?
Compass Therapeutics has traded in the range of US$ 0.765 to US$ 2.73 during the past year
What is the PE ratio of Compass Therapeutics?
The price to earnings ratio of Compass Therapeutics is -8.55
What is the reporting currency for Compass Therapeutics?
Compass Therapeutics reports financial results in USD
What is the latest annual profit for Compass Therapeutics?
The latest annual profit of Compass Therapeutics is USD -42.49M
What is the registered address of Compass Therapeutics?
The registered address for Compass Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Compass Therapeutics website address?
The website address for Compass Therapeutics is www.compasstherapeutics.com
Which industry sector does Compass Therapeutics operate in?
Compass Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
EVAXEvaxion Biotech AS
US$ 5.99
(64.56%)
55.41M
ELABPMGC Holdings Inc
US$ 3.0901
(56.07%)
76.48M
PCLAPicoCELA Inc
US$ 4.60
(49.35%)
3.75M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
GODNUGolden Star Acquisition Corporation
US$ 3.11
(-75.82%)
17.51k
GODNGolden Star Acquisition Corporation
US$ 2.93
(-65.67%)
902.76k
NXTTNext Technology Holding Inc
US$ 1.37
(-54.93%)
2.56M
SGLYSingularity Future Technology Ltd
US$ 1.625
(-38.45%)
917.77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90.11
(-38.07%)
8
ACONAclarion Inc
US$ 0.0557
(28.94%)
811.91M
NVNINVNI Group Ltd
US$ 4.38
(193.96%)
366.98M
RIMEAlgorhythm Holdings Inc
US$ 0.0357
(4.69%)
284.97M
GOEVCanoo Inc
US$ 0.475
(43.94%)
282.22M
NVDANVIDIA Corporation
US$ 142.62
(-3.12%)
232.88M

CMPX Discussion

게시물 보기
Tiger Money Tiger Money 2 일 전
What does this tell you?  Thanks!
👍️0
glenn1919 glenn1919 2 일 전
CMPX...........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 일 전
the upcoming trials....apparently someone(s) may know the results?  The initial indication is that they were very good 
👍️0
Bucks79 Bucks79 3 일 전
broke out after consolidation.. don't see any news released?
👍️0
glenn1919 glenn1919 3 일 전
CMPX..............https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
PonkenPlonken PonkenPlonken 6 일 전
listen to the webcasts and you will find mindblowing things every now and then. Like 6 out of 22 patients with 40% tumor decline in vegf dll4 monotherapy data.
And some people say theres a way to make the machine listen.
👍️0
Tiger Money Tiger Money 1 주 전
Someone must know something.... 
👍️0
Bucks79 Bucks79 1 주 전
a lot of action on this one in the last few days.
👍️0
glenn1919 glenn1919 2 주 전
CMPX........................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 주 전
Gap filled 
👍️0
PonkenPlonken PonkenPlonken 3 주 전
and they didnt even speak about it today!
👍️0
Tiger Money Tiger Money 3 주 전
Some very good news out this morning!
👍️0
glenn1919 glenn1919 3 주 전
CMPX..................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Tiger Money Tiger Money 3 주 전
Thanks!
👍️0
glenn1919 glenn1919 3 주 전
sideways................higher lows.....possible breakout
👍️0
Tiger Money Tiger Money 3 주 전
What does your work tell you on this?  Thanks 
👍️0
glenn1919 glenn1919 3 주 전
cmpx.........................https://stockcharts.com/h-sc/ui?s=cmpxp=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 월 전
CMPX, under $2
👍️0
PonkenPlonken PonkenPlonken 2 월 전
Sorry for the late reply, your question got lost in the mailbox.
I believe 3-6$ isnt unreasonable if they publish a nice readout.

i believe a handful of patients showed more than 30% tumor shrinkage in vegf monotherapy data... I havent seen similar to date...... Nobody listens to webcasts anymore - they probably need an anaylst note to alert them LOL
VEGf space is full of scammers to... everyone jumped the train
👍 1
Tiger Money Tiger Money 2 월 전
If so, where do you think that puts the stock?  Thanks 
👍️0
PonkenPlonken PonkenPlonken 2 월 전
Wouldnt be surprised to see a partner announced in the 10q
👍️0
PonkenPlonken PonkenPlonken 3 월 전
boom coming never before monotherapy data in VEGF space.... a place flooded by bio grifters
👍️0
Monksdream Monksdream 3 월 전
CMPX under $2
👍️0
PonkenPlonken PonkenPlonken 3 월 전
high volume yesterday
👍️0
PonkenPlonken PonkenPlonken 4 월 전
EXCELLENT monotherapy data
VEGF targeted agents usually need the chemo combination to even get a signifcant response. They get it in monotherapy.
I think its going to run into the H1 2025 data.
👍️0
Monksdream Monksdream 5 월 전
CMPX under $2
👍️0
glenn1919 glenn1919 5 월 전
CMPX........................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 월 전
CMPX....................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 6 월 전
CMPX under $2
👍️0
Monksdream Monksdream 10 월 전
CMPX 10Q due 3/25
👍️0
Monksdream Monksdream 10 월 전
CMPX 10Q due 3/18
👍️0
glenn1919 glenn1919 10 월 전
CMPX....................................https://stockcharts.com/h-sc/ui?s=CMPX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 월 전
Cant say offhand
Read the latest 10Q
👍️0
stockweiser stockweiser 11 월 전
Do you know there current cash on hand?
👍️0
Monksdream Monksdream 11 월 전
CMPX 10Q due March 11
👍️0
Monksdream Monksdream 1 년 전
CMPX new 52=week low
👍️0
Monksdream Monksdream 1 년 전
CMPX new 52 week low
👍️0
Monksdream Monksdream 1 년 전
CMPX under $2
👍️0
Copilotdog Copilotdog 1 년 전
Solid company
👍️0
Mktman2024 Mktman2024 2 년 전
Compass to review latest phase 2 progress with CTX 009 and other items at ASCO Jan 19-21.
Company moving slowly into the spotlight.
👍️0
Mktman2024 Mktman2024 2 년 전
Reminder CMPX is Compass Therapeutics ,,,EF Hutton new target 10
targets range from 8-15
👍️0
Mktman2024 Mktman2024 2 년 전
https://www.streetinsider.com/Corporate+News/Compass+Therapeutics%2C+Inc+%28CMPX%29+doses+first+patient+in+Phase+1b+CTX-471+combo+with+KEYTRUDA/20920046.html

now were talking!!
👍️0
Mktman2024 Mktman2024 2 년 전
amazing no one posts on any CMPX boards except twitter ...and even then crickets
👍️0
Mktman2024 Mktman2024 2 년 전
The proper company name associated with CMPX symbol
Compass Therapeutics . If one were to review the 6 or 7 bispecifics currently approved for cancer, the efficacy of CTX 009 , CTX 471 and CTX 8371 in early trials is astounding...with a very unique Moa...still not understood by most analysts. It clearly warrants a collaboration with Merck on 471 and potentially many others. The stitchmab they have developed is a real game changing technology optimizing the best suitable mab combinations , along with Taxol, Keytruda and others ...supercharging the efficacy of current drug therapies. This stock has multiple undervalued assets.
👍️0
Mktman2024 Mktman2024 2 년 전
Do you think they like their company ...a little??

Compass Therapeutics, Inc. Insider Trading Activity (benzinga.com)
👍️0
NO birds Allowed NO birds Allowed 2 년 전
dude WTF!!!! another ALLM
👍️0
NO birds Allowed NO birds Allowed 2 년 전
is eh CEO still buying?
👍️0
Mktman2024 Mktman2024 2 년 전
The relative outperformance continues stock sits at 3.05 .Phase 2/3 in US will begin Q4 ...more oustanding data to follow. 3X is easy with this one.
👍️0
Mktman2024 Mktman2024 2 년 전
CEO continues to buy stock buys another 15000 filed 8/17 owns over 5.3 million shares

https://ih.advfn.com/stock-market/NASDAQ/compass-therapeutics-CMPX/stock-news/88862025/statement-of-changes-in-beneficial-ownership-4
👍️0
Mktman2024 Mktman2024 2 년 전
Now we're talking !! 3.00 then 3.27 news might be coming fairly soon
New data plus CTX 009 US trial enrollment . winner..
👍️0

최근 히스토리

Delayed Upgrade Clock